The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population

Autor: H M, Westgeest, M C P, Kuppen, A J M, van den Eertwegh, R, de Wit, A M, Bergman, R J A, van Moorselaar, J L L M, Coenen, A C M, van den Bergh, D M, Somford, N, Mehra, I M, van Oort, K K H, Aben, W R, Gerritsen, C A, Uyl-de Groot

Publikováno v: Prostate cancer and prostatic diseases. 24(3)

In 2004 docetaxel was the first life-prolonging drug (LPD) registered for metastatic castration-resistant prostate cancer (mCRPC) patients. Between 2011 and 2014 new LPDs for mCRPC (cabazitaxel, abiraterone, enzalutamide, and radium-223) were introdu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::714fe7d207dd872e60a8cbc4144a2c5d
https://pubmed.ncbi.nlm.nih.gov/33746212

Measurements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease

Autor: C. T. B. M. Van Deursen, P. J. Brombacher, M.P. van Dieijen-Visser, J.W.J. van Wersch, J. van Pelt, M. M. F. Fickers, J. L. L. M. Coenen

Publikováno v: Clinical Chemistry. 37:560-563

We determined serum ferritin, C-reactive protein (CRP), fibrinogen, and the erythrocyte sedimentation rate (ESR) in 73 patients with anemia of chronic disease. Nomograms of CRP, ESR, or fibrinogen vs ferritin concentrations were constructed and used

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::62c126cf4708683198b97a3cf85f7283
https://doi.org/10.1093/clinchem/37.4.560

A breakthrough in cryosurgery

Autor: T. J. M. Reuers, Maaike A. Sikma, C. Kloosterziel, B. A. A. M. van Hasselt, J. L. L. M. Coenen

Publikováno v: Scopus-Elsevier
Surgical Endoscopy and Other Interventional Techniques, 16, 5, pp. 870
Surgical Endoscopy and Other Interventional Techniques, 16, 870

Item does not contain fulltext Liver cryosurgery is one of the treatment options for unresectable liver metastases. Indications for the use of this treatment instead of classic surgery are bilobar disease, location of the tumor at an irresectable ana

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d06b615e66e05ac6c6fc180a058248c1
https://pubmed.ncbi.nlm.nih.gov/11997844

Dose intensity of standard adjuvant CMF with granulocyte colony-stimulating factor for premenopausal patients with node-positive breast cancer

Autor: T. Tjabbes, H. de Graaf, H Piersma, E.G.E. de Vries, Phb Willemse, J. L. L. M. Coenen, H. Van Veelen, SB Bong

Publikováno v: Oncology : journal of clinical and experimental cancer research, 53(4), 289-294. KARGER

The effects of granulocyte colony-stimulating factor (G-CSF) on total dose and dose intensity of standard oral adjuvant CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) chemotherapy were studied in premenopausal patients with node-positive br

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91b5656de1f94889c948641fcd87565c
https://pubmed.ncbi.nlm.nih.gov/8692532

Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC)

Autor: P. C. Jong, S. J. Eelkman Rooda, Aafke H. Honkoop, C. J. Rodenburg, J. L. L. M. Coenen, J. Douma, P. H. T. H. J. Slee, R. S. Jong

Publikováno v: Journal of Clinical Oncology. 23:728-728

792 Background: There is a need for more effective 2nd line treatment options for MBC. Both docetaxel (D) and gemcitabine (G) have shown efficacy in MBC as single agents. Combination-chemotherapy, even in 2nd line, may have advantages over single age

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c81e2f1210108f14bc501bd16bf46d
https://doi.org/10.1200/jco.2005.23.16_suppl.728